Tat-immunoconjugates specifically inhibit the function of nuclear p21WAF-1/CIP-1 and differentially sensitize human breast cancer cells to antiproliferative agents

Hu M., Wang J., Chen P., Vallis K., Reilly R.

Type

Conference paper

Publication Date

2006-01-01T00:00:00+00:00

Volume

66

Permalink Close